Time and dose-related changes in radiological lung density after concurrent chemoradiotherapy for lung cancer

Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023

Karen Kelly, Kari Chansky, Laurie E. Gaspar et al. · Journal of Clinical Oncology · 2008 · 573 citations · Full text

Medicine, Oncology, Pharmacology +15

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial

Michele I. Saunders, Stanley Dische, Ann Barrett et al. · Radiotherapy and Oncology · 1999 · 483 citations

Medicine, Oncology, Radiation Oncology +13

Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters

Andrew Hope, Patricia Lindsay, Issam El Naqa et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 216 citations

Medicine, Radiation Oncology, Radiation Dosimetry +13

The Risk of Early and Late Lung Sequelae After Conformal Radiotherapy in Breast Cancer Patients

Zsuzsanna Kahán, Melinda Csenki, Zoltán Varga et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 139 citations

Medicine, Oncology, Radiation Oncology +12

Lung Density Changes After Stereotactic Radiotherapy: A Quantitative Analysis in 50 Patients

David A. Palma, John van Sörnsen de Koste, Wilko F.A.R. Verbakel et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 102 citations

Medicine, Oncology, Radiation Oncology +15